Professor Anat Loewenstein
Early detection in AMD: An ounce of prevention is worth a pound of cure
Interventions in AMD are most effective when administered early in the disease course. Studies provide evidence supporting this and a number of tools and techniques can be used to improve rates of early detection to improve patients’ long-term outcomes.
Dexamethasone for DME shows stronger results compared with sham group
In this article Dr Anat Lowenstein explains that the benefits of treatment with a dexamethasone intravitreal implant for DME were observed across a variety of demographic characteristics.
The future of anti-VEGF
This article provides a brief overview of the outcomes of a webex meeting hosted by Novartis at SOE 2013 in Copenhagen, Denmark.